Methanesulfonamide → US10023592, Example 159
Reaction equation
BrC1C2C(=CC=C(F)C=2)C(=O)N(C)C=1.CC1(C)C(C)(C)OB(B2OC(C)(C)C(C)(C)O2)O1.FC1C=C2C(=CC=1)C(=O)N(C)C=C2B1OC(C)(C)C(C)(C)O1.ClC1C(OCC2CC2)=CN=C(S(C)(=O)=O)N=1.[CH:71]1([CH2:74][O:75][C:76]2[C:77]([C:86]3[C:95]4[C:90](=[CH:91][CH:92]=[C:93]([F:96])[CH:94]=4)[C:89](=[O:97])[N:88]([CH3:98])[CH:87]=3)=[N:78][C:79](S(C)(=O)=O)=[N:80][CH:81]=2)[CH2:73][CH2:72]1.[CH3:99][S:100]([NH2:103])(=[O:102])=[O:101]>>[CH:71]1([CH2:74][O:75][C:76]2[C:77]([C:86]3[C:95]4[C:90](=[CH:91][CH:92]=[C:93]([F:96])[CH:94]=4)[C:89](=[O:97])[N:88]([CH3:98])[CH:87]=3)=[N:78][C:79]([NH:103][S:100]([CH3:99])(=[O:102])=[O:101])=[N:80][CH:81]=2)[CH2:72][CH2:73]1Participants
Reactant 6
Product 1
Procedure
The title compound of Example 47, step 2 was treated with 4,4,5,5-tetramethyl-2-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane in a manner similar to Example 89, step 1 and the resulting 6-fluoro-2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-1-one was coupled to the title compound of Example 152, step 4 in a manner similar to Example 152, step 5 and the resulting 4-[5-(cyclopropylmethoxy)-2-methylsulfonylpyrimidin-4-yl]-6-fluoro-2-methylisoquinolin-1-one was treated with MeSO2NH2 in a manner similar to Example 152, step 6 to give the title compound. 1H NMR (DMSO-d6, 400 MHz) δ 11.14 (brs, 1H), 8.56 (s, 1H), 7.96 (dd, J1=9.2 Hz, J2=3.2 Hz, 1H), 7.88 (s, 1H), 7.85 (dd, J1=9.2 Hz, J2=3.6 Hz, 1H), 7.62-7.55 (m, 1H), 3.94 (d, J=6.8 Hz, 2H), 3.60 (s, 3H), 3.32 (s, 3H), 1.11-0.99 (m, 1H), 0.47-0.40 (m, 2H), 0.23-0.16 (m, 2H). LCMS: 419.0 (M+1)+
Sources & evidence
- ORD record
- ord-7bab5d7670254f3aa48ad0f27e02a8e6
- Source dataset
- uspto-grants-2015_05
- Patent number
- US09034900B2
Reaction notes
Loading…